These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 20381815

  • 1. Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients.
    Stefani A, Alifano M, Bobbio A, Grigoroiu M, Jouni R, Magdeleinat P, Regnard JF.
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):356-63. PubMed ID: 20381815
    [Abstract] [Full Text] [Related]

  • 2. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, Splinter TA, Giaccone G, European Organisation for Research and Treatment of Cancer-Lung Cancer Group.
    J Natl Cancer Inst; 2007 Mar 21; 99(6):442-50. PubMed ID: 17374834
    [Abstract] [Full Text] [Related]

  • 3. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H, De Leyn P, Vansteenkiste J, Dooms C, Van Raemdonck D, Nafteux P, Coosemans W, Lerut T.
    Eur J Cardiothorac Surg; 2009 Sep 21; 36(3):433-9. PubMed ID: 19502079
    [Abstract] [Full Text] [Related]

  • 4. Surgical treatment of superior sulcus tumors: results and prognostic factors.
    Demir A, Sayar A, Kocaturk CI, Gunluoglu MZ, Akýn H, Metin M, Cansever L, Olcmen A, Dincer SI, Bedirhan MA, Gurses A.
    Thorac Cardiovasc Surg; 2009 Mar 21; 57(2):96-101. PubMed ID: 19241311
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH, Ra YJ, Kim YT, Jheon SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2008 Oct 21; 86(4):1092-7. PubMed ID: 18805138
    [Abstract] [Full Text] [Related]

  • 8. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
    Pezzetta E, Stupp R, Zouhair A, Guillou L, Taffé P, von Briel C, Krueger T, Ris HB.
    Eur J Cardiothorac Surg; 2005 Jun 21; 27(6):1092-8. PubMed ID: 15896624
    [Abstract] [Full Text] [Related]

  • 9. Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer.
    Higgins KA, Chino JP, Ready N, Onaitis MW, Berry MF, D'Amico TA, Kelsey CR.
    J Thorac Cardiovasc Surg; 2011 Nov 21; 142(5):1175-9. PubMed ID: 22014344
    [Abstract] [Full Text] [Related]

  • 10. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F.
    Eur J Cardiothorac Surg; 2008 May 21; 33(5):829-36. PubMed ID: 18367406
    [Abstract] [Full Text] [Related]

  • 11. Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.
    Takeda S, Maeda H, Okada T, Yamaguchi T, Nakagawa M, Yokota S, Sawabata N, Ohta M.
    Eur J Cardiothorac Surg; 2006 Jul 21; 30(1):184-9. PubMed ID: 16730452
    [Abstract] [Full Text] [Related]

  • 12. Pneumonectomy after chemotherapy: morbidity, mortality, and long-term outcome.
    Alifano M, Boudaya MS, Salvi M, Collet JY, Dinu C, Camilleri-Broët S, Régnard JF.
    Ann Thorac Surg; 2008 Jun 21; 85(6):1866-72; discussion 1872-3. PubMed ID: 18498785
    [Abstract] [Full Text] [Related]

  • 13. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
    Rice TW, Adelstein DJ, Koka A, Tefft M, Kirby TJ, Van Kirk MA, Taylor ME, Olencki TE, Peereboom D, Budd GT.
    Ann Thorac Surg; 1995 Sep 21; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
    [Abstract] [Full Text] [Related]

  • 14. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S, Faber LP.
    Ann Thorac Surg; 2009 Sep 21; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.
    Brock MV, Hooker CM, Syphard JE, Westra W, Xu L, Alberg AJ, Mason D, Baylin SB, Herman JG, Yung RC, Brahmer J, Rudin CM, Ettinger DS, Yang SC.
    J Thorac Cardiovasc Surg; 2005 Jan 21; 129(1):64-72. PubMed ID: 15632826
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group.
    J Thorac Cardiovasc Surg; 2003 Feb 21; 125(2):254-60. PubMed ID: 12579093
    [Abstract] [Full Text] [Related]

  • 18. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.
    J Thorac Cardiovasc Surg; 2004 Jan 21; 127(1):108-13. PubMed ID: 14752420
    [Abstract] [Full Text] [Related]

  • 19. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 20. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
    Cerfolio RJ, Bryant AS.
    Ann Thorac Surg; 2008 Aug 01; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.